LayerRx Mapping ID
733
Slot System
Featured Buckets
Featured Buckets Admin

What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?

Article Type
Changed
Tue, 12/18/2018 - 12:21
Display Headline
What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?
Article PDF
Author and Disclosure Information

Navneet S. Majhail, MD
Department of Internal Medicine, Cleveland Clinic

Alan E. Lichtin, MD
Department of Hematology and Oncology, Cleveland Clinic

Address: Alan E. Lichtin, MD, Department of Hematology and Oncology, R35, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Issue
Cleveland Clinic Journal of Medicine - 69(3)
Publications
Topics
Page Number
259-262
Sections
Author and Disclosure Information

Navneet S. Majhail, MD
Department of Internal Medicine, Cleveland Clinic

Alan E. Lichtin, MD
Department of Hematology and Oncology, Cleveland Clinic

Address: Alan E. Lichtin, MD, Department of Hematology and Oncology, R35, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Author and Disclosure Information

Navneet S. Majhail, MD
Department of Internal Medicine, Cleveland Clinic

Alan E. Lichtin, MD
Department of Hematology and Oncology, Cleveland Clinic

Address: Alan E. Lichtin, MD, Department of Hematology and Oncology, R35, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(3)
Issue
Cleveland Clinic Journal of Medicine - 69(3)
Page Number
259-262
Page Number
259-262
Publications
Publications
Topics
Article Type
Display Headline
What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?
Display Headline
What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Idiopathic retroperitoneal fibrosis: Prompt diagnosis preserves organ function

Article Type
Changed
Wed, 12/19/2018 - 09:52
Display Headline
Idiopathic retroperitoneal fibrosis: Prompt diagnosis preserves organ function
Article PDF
Author and Disclosure Information

Stefan Monev, MD
Department of Medicine, University of Mississippi Medical Center, Jackson, MS

Address: Stefan Monev, MD, University Hospital and Clinics-Holmes County, 675 Northwest Avenue, Durant, MS 39063

This paper discusses treatments that are not approved by the Food and Drug Administration (FDA) for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 69(2)
Publications
Topics
Page Number
160-166
Sections
Author and Disclosure Information

Stefan Monev, MD
Department of Medicine, University of Mississippi Medical Center, Jackson, MS

Address: Stefan Monev, MD, University Hospital and Clinics-Holmes County, 675 Northwest Avenue, Durant, MS 39063

This paper discusses treatments that are not approved by the Food and Drug Administration (FDA) for the use under discussion.

Author and Disclosure Information

Stefan Monev, MD
Department of Medicine, University of Mississippi Medical Center, Jackson, MS

Address: Stefan Monev, MD, University Hospital and Clinics-Holmes County, 675 Northwest Avenue, Durant, MS 39063

This paper discusses treatments that are not approved by the Food and Drug Administration (FDA) for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(2)
Issue
Cleveland Clinic Journal of Medicine - 69(2)
Page Number
160-166
Page Number
160-166
Publications
Publications
Topics
Article Type
Display Headline
Idiopathic retroperitoneal fibrosis: Prompt diagnosis preserves organ function
Display Headline
Idiopathic retroperitoneal fibrosis: Prompt diagnosis preserves organ function
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Caring for patients with prosthetic heart valves

Article Type
Changed
Wed, 12/19/2018 - 12:10
Display Headline
Caring for patients with prosthetic heart valves
Article PDF
Author and Disclosure Information

Monica S. Bettadapur, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Brian P. Griffin, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Craig R. Asher, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Craig R. Asher, MD, Department of Cardiology, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 69(1)
Publications
Topics
Page Number
75-87
Sections
Author and Disclosure Information

Monica S. Bettadapur, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Brian P. Griffin, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Craig R. Asher, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Craig R. Asher, MD, Department of Cardiology, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Monica S. Bettadapur, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Brian P. Griffin, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Craig R. Asher, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Craig R. Asher, MD, Department of Cardiology, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(1)
Issue
Cleveland Clinic Journal of Medicine - 69(1)
Page Number
75-87
Page Number
75-87
Publications
Publications
Topics
Article Type
Display Headline
Caring for patients with prosthetic heart valves
Display Headline
Caring for patients with prosthetic heart valves
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us

Article Type
Changed
Fri, 02/01/2019 - 10:36
Display Headline
GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
Article PDF
Author and Disclosure Information

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Issue
Cleveland Clinic Journal of Medicine - 68(12)
Publications
Topics
Page Number
1017-1023
Sections
Author and Disclosure Information

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Author and Disclosure Information

Derek P. Chew, MBBS
Department of Cardiovascular Medicine, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiovascular Medicine, Cleveland Clinic

Address: David J. Moliterno, MD, Department of Cardiovascular Medicine, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Moliterno has indicated that he has received grant or research support from the Centocor, Eli Lilly, and Merck corporations.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(12)
Issue
Cleveland Clinic Journal of Medicine - 68(12)
Page Number
1017-1023
Page Number
1017-1023
Publications
Publications
Topics
Article Type
Display Headline
GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
Display Headline
GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

How often are atrial septal defects associated with thromboembolism? When should they be looked for?

Article Type
Changed
Fri, 02/01/2019 - 08:55
Display Headline
How often are atrial septal defects associated with thromboembolism? When should they be looked for?
Article PDF
Author and Disclosure Information

Wael A. Jaber, MD
Department of Cardiology, Cleveland Clinic

Allan L. Klein, MD
Director, Cardiovascular Imaging Research, Professor of Medicine, Department of Cardiology, Cleveland Clinic

Address: Allan L. Klein, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Topics
Page Number
954-956
Sections
Author and Disclosure Information

Wael A. Jaber, MD
Department of Cardiology, Cleveland Clinic

Allan L. Klein, MD
Director, Cardiovascular Imaging Research, Professor of Medicine, Department of Cardiology, Cleveland Clinic

Address: Allan L. Klein, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Wael A. Jaber, MD
Department of Cardiology, Cleveland Clinic

Allan L. Klein, MD
Director, Cardiovascular Imaging Research, Professor of Medicine, Department of Cardiology, Cleveland Clinic

Address: Allan L. Klein, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
954-956
Page Number
954-956
Publications
Publications
Topics
Article Type
Display Headline
How often are atrial septal defects associated with thromboembolism? When should they be looked for?
Display Headline
How often are atrial septal defects associated with thromboembolism? When should they be looked for?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Management of primary headache: Serendipity and science

Article Type
Changed
Fri, 02/01/2019 - 08:11
Display Headline
Management of primary headache: Serendipity and science
Article PDF
Author and Disclosure Information

Glen D. Solomon, MD
Senior Medical Director, Department of Medical and Scientific Affairs, US Human Health, Merck and Company, Inc; consultant, Departments of Neurology and General Internal Medicine, The Cleveland Clinic

Address: Glen D. Solomon, MD, 42 Bradford Lane, Oak Brook, IL 60523

Dr. Solomon discusses therapies that are either investigative or not yet labeled for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Topics
Page Number
904, 906, 908, 910, 912
Sections
Author and Disclosure Information

Glen D. Solomon, MD
Senior Medical Director, Department of Medical and Scientific Affairs, US Human Health, Merck and Company, Inc; consultant, Departments of Neurology and General Internal Medicine, The Cleveland Clinic

Address: Glen D. Solomon, MD, 42 Bradford Lane, Oak Brook, IL 60523

Dr. Solomon discusses therapies that are either investigative or not yet labeled for the use under discussion.

Author and Disclosure Information

Glen D. Solomon, MD
Senior Medical Director, Department of Medical and Scientific Affairs, US Human Health, Merck and Company, Inc; consultant, Departments of Neurology and General Internal Medicine, The Cleveland Clinic

Address: Glen D. Solomon, MD, 42 Bradford Lane, Oak Brook, IL 60523

Dr. Solomon discusses therapies that are either investigative or not yet labeled for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
904, 906, 908, 910, 912
Page Number
904, 906, 908, 910, 912
Publications
Publications
Topics
Article Type
Display Headline
Management of primary headache: Serendipity and science
Display Headline
Management of primary headache: Serendipity and science
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

COX-2 inhibitors: Balancing the hope, the hype, and the concern

Article Type
Changed
Fri, 02/01/2019 - 08:06
Display Headline
COX-2 inhibitors: Balancing the hope, the hype, and the concern
Article PDF
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Topics
Page Number
899
Sections
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
899
Page Number
899
Publications
Publications
Topics
Article Type
Display Headline
COX-2 inhibitors: Balancing the hope, the hype, and the concern
Display Headline
COX-2 inhibitors: Balancing the hope, the hype, and the concern
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

COX-2 inhibitors and cardiovascular risk: We defend our data and suggest caution

Article Type
Changed
Fri, 02/01/2019 - 09:13
Display Headline
COX-2 inhibitors and cardiovascular risk: We defend our data and suggest caution
Article PDF
Author and Disclosure Information

Debabrata Mukherjee, MD
Assistant Professor, Division of Cardiology, University of Michigan Health System, Ann Arbor

Steven E. Nissen, MD
Vice Chairman, Department of Cardiovascular Medicine, Director of Clinical Cardiology,  Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Debabrata Mukherjee, MD, Assistant Professor, Division of Cardiology, University of Michigan Health System, University Hospital, B1-F245, 1500 E Medical Center Drive, Ann Arbor, MI 48103-0022; [email protected]

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Topics
Page Number
963-964
Sections
Author and Disclosure Information

Debabrata Mukherjee, MD
Assistant Professor, Division of Cardiology, University of Michigan Health System, Ann Arbor

Steven E. Nissen, MD
Vice Chairman, Department of Cardiovascular Medicine, Director of Clinical Cardiology,  Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Debabrata Mukherjee, MD, Assistant Professor, Division of Cardiology, University of Michigan Health System, University Hospital, B1-F245, 1500 E Medical Center Drive, Ann Arbor, MI 48103-0022; [email protected]

Author and Disclosure Information

Debabrata Mukherjee, MD
Assistant Professor, Division of Cardiology, University of Michigan Health System, Ann Arbor

Steven E. Nissen, MD
Vice Chairman, Department of Cardiovascular Medicine, Director of Clinical Cardiology,  Cleveland Clinic

Eric J. Topol, MD
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Debabrata Mukherjee, MD, Assistant Professor, Division of Cardiology, University of Michigan Health System, University Hospital, B1-F245, 1500 E Medical Center Drive, Ann Arbor, MI 48103-0022; [email protected]

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
963-964
Page Number
963-964
Publications
Publications
Topics
Article Type
Display Headline
COX-2 inhibitors and cardiovascular risk: We defend our data and suggest caution
Display Headline
COX-2 inhibitors and cardiovascular risk: We defend our data and suggest caution
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed

Article Type
Changed
Fri, 02/01/2019 - 09:09
Display Headline
COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed
Article PDF
Author and Disclosure Information

John Lipani, MD
Clinical rheumatologist and researcher; president, Histatek Inc., Fountain Hills, AZ

Address: John Lipani, MD, 16107 East Emerald Drive, #102, Fountain Hills, AZ 85268

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Topics
Page Number
961-962
Sections
Author and Disclosure Information

John Lipani, MD
Clinical rheumatologist and researcher; president, Histatek Inc., Fountain Hills, AZ

Address: John Lipani, MD, 16107 East Emerald Drive, #102, Fountain Hills, AZ 85268

Author and Disclosure Information

John Lipani, MD
Clinical rheumatologist and researcher; president, Histatek Inc., Fountain Hills, AZ

Address: John Lipani, MD, 16107 East Emerald Drive, #102, Fountain Hills, AZ 85268

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
961-962
Page Number
961-962
Publications
Publications
Topics
Article Type
Display Headline
COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed
Display Headline
COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

COX-2 inhibitors and cardiovascular risk: Point and counterpoint

Article Type
Changed
Fri, 02/01/2019 - 09:02
Display Headline
COX-2 inhibitors and cardiovascular risk: Point and counterpoint
Article PDF
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases and Senior Associate Program Director, Internal Medicine Residency Program, Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, FACR, Cleveland Clinic Journal of Medicine, NA32,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has received honoraria, research support, or donations to educational programs from the Centocor, Merck, Pfizer, Searle, SmithKline Beecham, and Wyeth Pharmaceutical corporations.

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Topics
Page Number
957-960
Sections
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases and Senior Associate Program Director, Internal Medicine Residency Program, Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, FACR, Cleveland Clinic Journal of Medicine, NA32,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has received honoraria, research support, or donations to educational programs from the Centocor, Merck, Pfizer, Searle, SmithKline Beecham, and Wyeth Pharmaceutical corporations.

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Department of Rheumatic and Immunologic Diseases and Senior Associate Program Director, Internal Medicine Residency Program, Cleveland Clinic; Deputy Editor, Cleveland Clinic Journal of Medicine

Address: Brian F. Mandell, MD, PhD, FACR, Cleveland Clinic Journal of Medicine, NA32,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Mandell has received honoraria, research support, or donations to educational programs from the Centocor, Merck, Pfizer, Searle, SmithKline Beecham, and Wyeth Pharmaceutical corporations.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
957-960
Page Number
957-960
Publications
Publications
Topics
Article Type
Display Headline
COX-2 inhibitors and cardiovascular risk: Point and counterpoint
Display Headline
COX-2 inhibitors and cardiovascular risk: Point and counterpoint
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media